Stock data

浩鼎 (4174)

浩鼎 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$1.62M, down 69.7% from a year earlier. EPS over the last four quarters totals -NT$16.03.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 浩鼎 in Insightr